+234 905 3023 466

Qinghao Capsules: A Scientifically-Backed Breakthrough in Fighting Resistant Malaria

Malaria remains one of the world’s most devastating life-threatening diseases. According to the World Health Organization (WHO)’s 2023 World Malaria Report, there were an estimated 249 million malaria cases and 608,000 malaria deaths globally in 2022. Nearly half the world’s population, particularly in developing nations across Africa and Southeast Asia, remains at risk. This deadly disease, transmitted through the bites of infected Anopheles mosquitoes, sees the Plasmodium parasite invade the bloodstream, multiply in the liver, and destroy red blood cells, leading to debilitating symptoms like high fever, severe chills, profuse sweating, and organ failure.

In this ongoing battle, the rise of drug-resistant parasites poses a critical threat to global health efforts. Qinghao Capsule stands out as a potent, trusted, and scientifically-backed solution designed to meet this challenge head-on.


1 Treatment Pack (6-8 capsules based on dosage)

The Nobel-Prize Winning Foundation: The Power of Artemisinin

The unparalleled efficacy of Qinghao Capsule is rooted in one of the most significant medical discoveries of the 20th century. In 2015, Professor Youyou Tu was awarded the Nobel Prize in Physiology or Medicine for her groundbreaking work in extracting Artemisinin from the plant Artemisia annua (Sweet Wormwood).

By applying knowledge from ancient Traditional Chinese Medicine texts, Professor Tu revolutionized malaria treatment. Today, Artemisinin-based Combination Therapies (ACTs) are the World Health Organization’s (WHO) recommended first-line treatment for uncomplicated P. falciparum malaria worldwide. Qinghao Capsule harnesses the full power of this Nobel Prize-winning discovery in a single, effective formulation.

How Does Qinghao Capsule Work Against Resistant Malaria?

Qinghao Capsule contains a powerful, synergistic combination of two active ingredients that attack the malaria parasite on multiple fronts to prevent resistance and ensure a complete cure:

  • Dihydroartemisinin (40mg): This is a potent and fast-acting derivative of Artemisinin. It targets the parasite during its critical erythrocytic phase (when it infects and multiplies within red blood cells). Artemisinin compounds produce free radicals that form a “peroxide bridge,” damaging the parasite’s essential proteins and cell membranes. This leads to a rapid loss of cytoplasm and nutrients, causing the swift termination of up to 99.9% of parasites within the first 48 hours, drastically reducing parasite load and alleviating severe symptoms.
  • Piperaquine Phosphate (320mg): This long-acting partner drug is crucial for clearing any residual parasites that survive the initial assault. It provides a prolonged protective effect (post-treatment prophylaxis), preventing recrudescence (recurrence) and ensuring a complete radical cure. This dual-mechanism is specifically designed to overcome and prevent multi-drug resistance.

Key Benefits of Choosing Qinghao Capsule:

  • Proven Efficacy Against Resistant Strains: Formulated to combat Plasmodium falciparum and the growing threat of multi-drug resistant malaria strains, a critical tool in regions where resistance to older therapies is high.
  • Rapid Action and Symptom Relief: The Artemisinin component begins working within hours to dramatically reduce parasite load, helping to alleviate severe fevers, chills, and other debilitating symptoms quickly.
  • WHO-Compliant Formulation: As a recognized Artemisinin Combination Therapy (ACT), it adheres to the global gold standard for malaria treatment.
  • Herbal-Based with Immune Support: Sourced from the Sweet Wormwood plant, it offers natural immune-boosting benefits alongside its direct, powerful antimalarial action.
  • Market-Tested and Globally Trusted: With over a decade of proven success in clinical and real-world settings, Qinghao Capsule has helped millions of individuals across Africa and other malaria-endemic regions regain their health.

Qinghao Capsule: At a Glance

Active IngredientsDihydroartemisinin 40mg & Piperaquine Phosphate 320mg
Primary UseTreatment of all forms of malaria, especially those caused by Plasmodium falciparum
DosageAlways follow a healthcare provider’s instructions. Typically a 3-day course with dosage based on patient weight.
Key AdvantageHighly effective against multi-drug resistant malaria strains
FormulationHerbal-based Artemisinin Combination Therapy (ACT)

Take Action Against Malaria Today

Don’t let malaria disrupt your life or endanger your family. With effective, fast-acting treatment, a full recovery is within reach.

For immediate consultation, to place an order, or for dosage instructions, contact our healthcare experts directly on WhatsApp:

📞 +234 905 3023 466

Our team is available to provide guidance and ensure you receive the correct treatment for your needs.

Disclaimer

This information is for educational purposes only. Malaria is a serious medical condition that requires professional diagnosis and treatment. The statistics provided are based on the latest WHO reports. Always consult with a qualified healthcare provider before starting any new medication to ensure it is appropriate for your specific health situation. Self-diagnosis and self-medication can be dangerous.